Quantinno Capital Management LP lifted its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 169.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 41,004 shares of the company's stock after purchasing an additional 25,774 shares during the quarter. Quantinno Capital Management LP's holdings in Clorox were worth $6,660,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares during the period. Redwood Park Advisors LLC acquired a new position in shares of Clorox during the 4th quarter worth $26,000. Millstone Evans Group LLC acquired a new position in shares of Clorox during the 4th quarter worth $31,000. Asset Planning Inc acquired a new position in shares of Clorox during the 4th quarter worth $32,000. Finally, GKV Capital Management Co. Inc. acquired a new position in shares of Clorox during the 4th quarter worth $32,000. 78.53% of the stock is owned by institutional investors and hedge funds.
Clorox Trading Down 0.5%
NYSE CLX traded down $0.68 during mid-day trading on Thursday, hitting $131.19. The company's stock had a trading volume of 482,771 shares, compared to its average volume of 1,324,469. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The stock's fifty day simple moving average is $140.26 and its two-hundred day simple moving average is $152.82. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm has a market capitalization of $16.17 billion, a P/E ratio of 35.86, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60.
Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter in the previous year, the business posted $1.71 EPS. The company's quarterly revenue was down 8.0% on a year-over-year basis. Research analysts expect that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd were given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.72%. The ex-dividend date of this dividend was Wednesday, April 23rd. Clorox's payout ratio is currently 87.61%.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on the stock. Barclays lowered their price objective on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a research note on Wednesday, May 7th. Morgan Stanley lowered their price objective on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Royal Bank of Canada reissued a "sector perform" rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. Finally, DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of "Hold" and an average target price of $151.23.
Get Our Latest Stock Analysis on Clorox
Insider Transactions at Clorox
In related news, Director Pierre R. Breber bought 4,000 shares of the business's stock in a transaction on Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the purchase, the director now owns 4,000 shares of the company's stock, valued at $546,280. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.57% of the company's stock.
Clorox Company Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
